Browse the evidence

31P-MRS based PCr resynthesis may represent a valid non-invasive surrogate marker of mitochondrial NAMPT in human skeletal muscle.

31P-MRS can be used as a non-invasive method to assess mitochondrial health in muscle.

Compounds K2 and K5 decreased and maintained the body weight of diet-induced obese mice.

Compounds K2 and K5 may be potential candidates for drug development targeting obesity.

The study proposes an approach for treating overweight and obese patients by preventing or reducing CCK1 activation.

This approach may inform future obesity treatments focusing on CCK1 regulation.

Adipose tissue browning is linked to improved metabolic and cardiovascular health.

Promoting adipose tissue browning may enhance metabolic and cardiovascular health.

White adipose tissue browning mitigates inflammation and improves cardiometabolic health.

Encouraging white adipose tissue browning may reduce inflammation and enhance cardiometabolic health.

There was a greater decrease in total cholesterol in the refined grain group compared to the whole grain group.

Practitioners should be aware that refined grains may lead to better cholesterol outcomes in this context.

Newer classes of antihyperglycemic agents have beneficial effects on several cardiovascular risk factors.

Healthcare providers should consider prescribing newer antihyperglycemic agents for their cardiovascular benefits.

A one standard deviation higher polygenic score (PS) related to a smaller one-year change in waist circumference adjusted for body mass index (WCadjBMI) in the lifestyle intervention arms at year 1, predicting poorer response among White participants overall.

Practitioners should consider genetic factors when assessing weight loss responses in individuals.

The effect of polygenic risk on change in WCadjBMI with lifestyle intervention is small and not of sufficient magnitude to be clinically significant.

Genetic factors may play a role in weight loss, but their impact may not be significant enough to warrant changes in intervention strategies.

Modern pharmacotherapies are fundamental to CKD prevention.

Incorporate modern pharmacotherapies into CKD prevention strategies.

Circadian cues direct hormones, enzymes, and molecular signals.

Recognizing the impact of circadian cues can aid in timing interventions for better health outcomes.

The Mediterranean Adequacy Index (MAI) is inversely correlated with the Atherogenicity (ATI) index (R = -0.91).

Practitioners should consider the MAI as a significant dietary factor in cardiovascular health.

Atherogenicity (ATI) is directly correlated with serum cholesterol (R = +0.73).

Practitioners should monitor serum cholesterol levels in relation to dietary fatty acid intake.

Atherogenicity (ATI) and Thrombogenicity (THI) indices are strongly associated with long-term coronary heart disease (CHD) mortality.

Practitioners should consider the impact of dietary fatty acids on long-term CHD risk.

Emerging biomarkers and diagnostic tools could improve early detection of diabetic neuropathy.

Practitioners should consider new biomarkers for better early diagnosis of diabetic neuropathy.

Genetic inheritance significantly influences individual susceptibility to obesity.

Practitioners should consider genetic factors when assessing obesity risk.

IgG antibody concentrations decreased in 60% of the foods in the waitlist group.

Even without intervention, some individuals may experience changes in IgG levels.

T2DM-associated sphingolipids were associated with poorer memory, attention, and psychomotor processing speed performance.

Practitioners should consider the impact of T2DM-related sphingolipids on cognitive performance in patients with CAD.

Bioactive metabolites produced by fatty acid oxygenases mediate many biological functions of omega-3 PUFAs.

Understanding the role of metabolites can help in developing targeted nutritional strategies.

The FDA-approved label for resmetirom does not require liver biopsy to confirm the diagnosis of fibrotic MASH.

Clinicians can diagnose fibrotic MASH without the need for invasive liver biopsy, simplifying patient assessment.

Nutritional biology can significantly contribute to the discovery of new molecular targets.

Practitioners should consider the role of nutrition in identifying new treatment targets.

Several mechanisms may mediate the association between NAFLD and CVD.

Understanding these mechanisms can help in developing targeted interventions for patients with NAFLD.

SCD1 inhibitors have been developed to treat various types of cancer.

SCD1 inhibitors could be a promising avenue for cancer therapy.

RMR was not related to any markers of oxidative stress.

Practitioners may need to reconsider the role of metabolic rate in oxidative stress and aging.